February 2024 in “Cosmoderma” Low-dose oral minoxidil can help treat male and female pattern hair loss, especially in those who can't use topical treatments or have heart health issues.
8 citations
,
October 2015 in “PubMed” 5% minoxidil foam effectively treats female hair loss.
May 2015 in “Journal of The American Academy of Dermatology” 5% minoxidil foam helps women with thinning hair.
April 2011 in “The FASEB Journal” Topical Minoxidil is cost-effective for managing baldness but requires continuous use.
1 citations
,
September 2002 in “PubMed” Minoxidil helps stimulate hair growth and reduce hair loss in women with androgenic alopecia.
127 citations
,
July 1996 in “Journal of The American Academy of Dermatology” Minoxidil shortens baldness from chemotherapy by 50.2 days without significant side effects.
36 citations
,
January 1991 in “PubMed” This pilot study tested the effect of 2% Minoxidil on preventing hair loss during chemotherapy for gynecologic cancers in 10 women. Each participant served as her own control, with only part of the scalp treated. Four patients were unevaluable due to non-compliance. Among the six evaluable patients, five experienced significant hair loss within four weeks of starting chemotherapy, while one had no hair loss in either treated or untreated areas. The study concluded that 2% Minoxidil was non-toxic but ineffective in preventing chemotherapy-induced alopecia.
September 1989 in “Drug and Therapeutics Bulletin” The document discussed the use of a 2% topical minoxidil solution, marketed as Regaine, which was introduced in the UK in 1988 for treating male-pattern baldness. While oral minoxidil, used for hypertension, often caused increased hair growth (hypertrichosis) and occasionally improved male-pattern baldness, the topical version aimed to stimulate hair growth without systemic side effects. However, it was not licensed for use by women or for other types of baldness and was only available through private prescription.
